Literature DB >> 20084125

Syncope in children and adolescents: Evaluation and treatment.

J M Côté1.   

Abstract

Syncope in children is most often neurally mediated and usually has a natural history of spontaneous resolution or improvement. Syncope is defined as the temporary loss of consciousness resulting from a reversible disturbance of cerebral function. It is characterized by a loss of consciousness due to a lack of cerebral blood flow, rapid or sudden onset, falling of the patient, if not supported, and transiency of the attack. In children, it is most often benign, but may sometimes herald a more serious, potentially life-threatening cause. The main purpose of the present paper is to propose an evaluation scheme that will allow the physician involved in the care of children to differentiate the life-threatening causes of syncope with potential for injury or sudden death from the common, more benign neurally mediated syncope. Secondarily, the present article facilitates the identification of the patient with neurally mediated syncope who may benefit from medical therapy and distinguishes syncope from the more frequent noncardiac 'spells' of childhood.

Entities:  

Keywords:  Evaluation; Syncope

Year:  2001        PMID: 20084125      PMCID: PMC2805591          DOI: 10.1093/pch/6.8.549

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  10 in total

Review 1.  Unexplained syncope: clinical management.

Authors:  G S Wolff
Journal:  Pacing Clin Electrophysiol       Date:  1997-08       Impact factor: 1.976

2.  Specificity of head-up tilt testing in adolescents: effect of various degrees of tilt challenge in normal control subjects.

Authors:  D A Lewis; J Zlotocha; L Henke; A Dhala
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

Review 3.  Cardiovascular evaluation of the young athlete.

Authors:  E F Luckstead
Journal:  Adolesc Med       Date:  1998-10

Review 4.  The diagnosis and management of syncope in children and adolescents.

Authors:  D S Braden; C H Gaymes
Journal:  Pediatr Ann       Date:  1997-07       Impact factor: 1.132

Review 5.  Syncope in the pediatric patient.

Authors:  R E Tanel; E P Walsh
Journal:  Cardiol Clin       Date:  1997-05       Impact factor: 2.213

6.  A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope.

Authors:  M Brignole; C Menozzi; L Gianfranchi; G Lolli; N Bottoni; D Oddone
Journal:  Am J Cardiol       Date:  1992-08-01       Impact factor: 2.778

7.  Head-up tilt for the evaluation of syncope of unknown origin in children.

Authors:  T Lerman-Sagie; E Rechavia; B Strasberg; A Sagie; L Blieden; M Mimouni
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

8.  Sensitivity and specificity of the tilt table test in young patients with unexplained syncope.

Authors:  F M Fouad; S Sitthisook; G Vanerio; J Maloney; M Okabe; F Jaeger; M Schluchter; J D Maloney
Journal:  Pacing Clin Electrophysiol       Date:  1993-03       Impact factor: 1.976

9.  Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.

Authors:  H Calkins; M Seifert; F Morady
Journal:  Am Heart J       Date:  1995-06       Impact factor: 4.749

10.  A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.

Authors:  C A Morillo; J W Leitch; R Yee; G J Klein
Journal:  J Am Coll Cardiol       Date:  1993-12       Impact factor: 24.094

  10 in total
  3 in total

1.  Fainting attacks in children.

Authors:  Kirti M Naranje; Arun Bansal; Sunit C Singhi
Journal:  Indian J Pediatr       Date:  2011-06-22       Impact factor: 1.967

Review 2.  Gastrointestinal and Autonomic Symptoms-How to Improve the Diagnostic Process in Panayiotopoulos Syndrome?

Authors:  Aneta Zontek; Justyna Paprocka
Journal:  Children (Basel)       Date:  2022-05-31

3.  The Repolarization Period during the Head-Up Tilt Test in Children with Vasovagal Syncope.

Authors:  Ewelina Kolarczyk; Grażyna Markiewicz-Łoskot; Lesław Szydłowski
Journal:  Int J Environ Res Public Health       Date:  2020-03-15       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.